Cargando…

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies

Detalles Bibliográficos
Autores principales:	Mahfoud, Felix, Azizi, Michel, Ewen, Sebastian, Pathak, Atul, Ukena, Christian, Blankestijn, Peter J, Böhm, Michael, Burnier, Michel, Chatellier, Gilles, Durand Zaleski, Isabelle, Grassi, Guido, Joner, Michael, Kandzari, David E, Kirtane, Ajay, Kjeldsen, Sverre E, Lobo, Melvin D, Lüscher, Thomas F, McEvoy, John William, Parati, Gianfranco, Rossignol, Patrick, Ruilope, Luis, Schlaich, Markus P, Shahzad, Atif, Sharif, Faisal, Sharp, Andrew S P, Sievert, Horst, Volpe, Massimo, Weber, Michael A, Schmieder, Roland E, Tsioufis, Costas, Wijns, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174031/ https://www.ncbi.nlm.nih.gov/pubmed/32211888 http://dx.doi.org/10.1093/eurheartj/ehaa121

Ejemplares similares

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future
por: Mahfoud, Felix, et al.
Publicado: (2017)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
por: Kandzari, David E., et al.
Publicado: (2022)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2019)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry
por: Schmieder, Roland E, et al.
Publicado: (2022)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial
por: Weber, Thomas, et al.
Publicado: (2022)

Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model
por: Sharp, Andrew S.P., et al.
Publicado: (2022)

The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study
por: Schmieder, Roland E., et al.
Publicado: (2016)

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
por: Weber, Michael A., et al.
Publicado: (2022)

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study
por: Saxena, Manish, et al.
Publicado: (2021)

Treating resistant hypertension: role of renal denervation
por: Urban, Daniel, et al.
Publicado: (2013)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions
por: Böhm, Michael, et al.
Publicado: (2021)

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)

Cardiovascular risk reduction by reversing endothelial dysfunction:ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme
por: Ruilope, Luis Miguel, et al.
Publicado: (2007)

Renal denervation reduces left ventricular mass in patients with resistant hypertension - results from a multicenter CMR-study
por: Mahfoud, Felix, et al.
Publicado: (2013)

HEAVY ALCOHOL CONSUMPTION IN MIDLIFE IS ASSOCIATED WITH ACCELERATED BRAIN AGING SIX YEARS LATER
por: Slayday, Riki E, et al.
Publicado: (2019)

Reduction in Basal Nitric Oxide Activity Causes Albuminuria
por: Ott, Christian, et al.
Publicado: (2011)

Prediction of conduction disturbances in patients undergoing transcatheter aortic valve replacement
por: Pavlicek, Valérie, et al.
Publicado: (2023)

Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
por: Burnier, Michel
Publicado: (2010)

Is There a Threshold for Medication Adherence? Lessons Learnt From Electronic Monitoring of Drug Adherence
por: Burnier, Michel
Publicado: (2019)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Commentary: Statistical Adhockeries Are No Criteria for Legal Decisions—The Case of the Expert Medical Report on the Assessment of Urine Specimens Collected Among Athletes Having Participated to the Vancouver and Sochi Winter Olympic Games
por: Burnier, Michel
Publicado: (2019)

Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?
por: Burnier, Michel
Publicado: (2021)

Editorial: Insights in hypertension: 2021
por: Burnier, Michel
Publicado: (2022)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)

Sympatho-renal axis in chronic disease
por: Sobotka, Paul A., et al.
Publicado: (2011)

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2017)

Renal denervation in the antihypertensive arsenal – knowns and known unknowns
por: Messerli, Franz H., et al.
Publicado: (2023)

Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses
por: Kjeldsen, Sverre E., et al.
Publicado: (2016)

Atrial stimulation protocols to test inducibility of atrial fibrillation
por: Fischer, P, et al.
Publicado: (2023)

Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer’s disease
por: Vuoksimaa, Eero, et al.
Publicado: (2018)

Correction to: One‑year clinical outcomes in patients with renal insuffciency after contemporary PCI: data from a multicenter registry
por: Scholz, Sean S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e7m4q4t3ej6ir1tr1m48f15dt8